Tumour progression: Random mutations or an integrated survival response to cellular stress conserved from unicellular organisms?

Journal of Theoretical Biology

Volumn 178, Issue 4, 1996, Pages 375-380

  Israel, Lucien ^a  

^a UNIVERSITÉ PARIS 13   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CANCER GENETICS; CANCER GROWTH; CELL PROLIFERATION; CELL SURVIVAL; GENE MUTATION; GENETIC REGULATION; ONCOGENE; PRIORITY JOURNAL;

EID: 0029866975     PISSN: 00225193     EISSN: None     Source Type: Journal    
DOI: 10.1006/jtbi.1996.0033     Document Type: Article

References (80)

1. AARONSON S. A. (1991). Growth factors and cancer. Science 254, 1146-1153.
2. ADAM L., CREPIN M., LELONG J. C., SPANAKIS E. & ISRAEL L. (1994). Selective interactions between mammary epithelial cells and fibroblasts in co-culture. Int. J. Cancer 59, 262-268.
3. ALEXANDER P. (1985). The biology of metastases. Cancer Topics 5, 1, 6-8.
4. BARRITT G. J. (1992). Communication within Animal Cells. Oxford: Science Publications.
5. BATES R. C., BURET A., VANHELDEN D. F., HORTON M. A. & BURNS G. F. (1994). Apoptosis induced by inhibition of intercellular contact. J. Cell Biol. 125, 403-415.
6. BLOOD C. H. & ZELTER B. R. (1990). Tumor interaction with the vasculature. Bioch. Biophy. Acta 1032, 89-118.
7. BURRIDGE K. et al. (1988). Focal adhesions: transmembrane junctions between the extracellular matrix and the cytoskeleton. Ann. Rev. Cell. Biol. 4, 487-526.
8. CADMAN E., WONG D. & LIU F. (1986). Drug resistance genes can be spontaneously transferred among malignant cells. In: Cancer Drug Resistance. (Hall T. ed.) New York: Alan Liss Press.
9. CAIRNS J. (1975). Mutational selection and the natural history of cancer. Nature 255, 197-200.
10. CHIN K. V., PASTAN I. & GOTTESTRAN M. M. (1993). Function and regulation of the human multidrug-resistance gene. Adv. Cancer Res. 60, 157-180.
11. CHOWO M., TAO A. & RUBIN H. (1994). Cellular epigenetics: topochronology of progressive "spontaneous" transformation of cells under growth constraints. Proc. Natl. Acad. Sci. 91, 599-603.
12. DELCLOS K. B., NAGLE D. S. & BLUMBERG P. M. (1980). Specific binding of phorbol ester tumor promoters to mouse skin. Cell 19, 1025-1032.
13. FANG W., HARTMANN N., CHOW D. T., RIEGEL A. T. & WELOSTEIN A. (1992). Pleiotrophin stimulates fibroblasts and epithelial cells and is expressed in human cancer. J. Biol. Chem. 267, 2582-2587.
14. FOJO A. T., VEDA K., SLAMON D. S. et al. (1987). Expression of a multidrug-resistance gene in human tumors and tissues. Proc. Natl. Acad. Sci. USA 84, 265-269.
15. FOLKMAN J., WATSON K., INGLER D. & HANAHAN D. (1989). Induction of antiogenesis during the transition from hyperplasia to neoplasia. Nature 339, 58-61.
16. FRENCH L. E., WOHLWEND A., SAPPINO A. P., TSCHOPP J. & SCKIFFERI J. A. (1994). Human clusterin gene expression is confined to surviving cells during in vitro programmed cell death. J. Clin. Invest. 93, 877-884.
17. FRIEDBERG E. C., WALKER G. & SIEDE W. (1995). SOS responses and DNA damage tolerance in prokaryotes. In: DNA Repair and Mutagenesis. Washington: ASM Press.
18. FRIEDBERG E. C., WALKER G. C. & SIEDE W. (1995). Mismatch repair. In: DNA Repair and Mutagenesis. Washington: ASM Press.
19. FULLER K. J., ISSELS O., GUILLET J. G., SOUSSI T. & POLLA B. S. (1994). Cancer and the heat shock proteins. Eur. J. Cancer, 30A, 1884-1891.
20. HAIMOVITZ-FRIEDMAN A., WLODAVSKY I., CHANDURI A., WITTE L. & FUKS Z. (1991). Autocrine effects of fibroblast growth factor in repair of radiation damage in endothelial cells. Cancer Res. 51, 2552-2558.
21. HALL T. (1986). Cancer drug resistance Vol. 1. New York: Alan Liss Press.
22. HOCKEN-BERY M. D., OLTAVAI N., YIN X. M., MILLIMAN C. L. & KORSMEYER J. J. (1993). Bcl2 functions as an antioxidant pathway to prevent apoptosis. Cell 75, 241-251.
23. HOLLINGSWORTH R. E. JR, HENSEY C. E. & LEE W. H. (1993). Retinoblastoma protein and the cell cycle. Cur. Opin. Genet. Dev. 3, 55-62.
24. HORII T., OGAWA T., NAKATANI T., HASE T., MATSUBARA H. & OGAWA H. (1981). Regulation of SOS functions: purification of E. coli Lex A protein and determination of its specific site cleaved by the Rec A protein. Cell 27, 515-522.
25. ISRAEL L. & CHAHINIAN P. (1976). Rates and patterns of growth of lung cancer. In: Lung Cancer: Natural History Prognosis and Therapy. New York: Academic Press.
26. ISRAEL L., SAMAK R. & EDELSTEIN R. (1980). Defective monocyte killing in cancer patients. Lancet 8207, 1311.
27. ISRAEL L., SAMAK R., EDELSTEIN R., AMOUROUX J., BATTESTI J. P. & DE SAINT-FLORENT G. (1982). In vivo non-specific macrophage chemotaxis in cancer patients and its correlation with extent of disease, regional lymphe node status and disease free survival. Cancer Res. 42, 2489-2493.
28. ISRAEL L., HAJJI F., RIGAUD J. P. & AMOUROUX J. (1984). Thymus function in patients with resectable lung carcinoma. Cancer Immunol. Immunopath. 18, 24-28.
29. ISRAEL L. & BAND P. (1984). Hormones as cancer growth factors. Lancet 8407, 843-844.
30. ISRAEL L. (1990). Antiprostaglandins and cancer. Pathol. Biol. 38, 8, 791.
31. ISRAEL L. (1990). Accelerated genetic instability and dormancy: two distinct causes of resistance in metastatic cells. Clinical magnitude therapeutic approaches. Clin. Exp. Metast. 8, 1-11.
32. ISRAEL L. (1991). Le phénomène cancéreux. In: Manuel de Therapeutique Médical, Masson, Paris.
33. ISRAEL L. (1994). The behavior of metastases from spontaneous human tumors: therapeutic possibilities and limitations. Bull. Inst. Pasteur, 92, 4, 230-234.
34. KHATIB Z. A., MATSUCHIME H., VALENTINE M. et al. (1993). Co-amplification of the CD4 gene with mdm2 and GLI in human sarcomas. Cancer Res. 53, 5535-5541.
35. KIM N. W., PIATYSEK M. A., PROWSE K. R., HARLEY C. B., WEST M. D., HO P. L. C., et al. (1994). Specific association of human telomerase activity with immortal cells and cancer. Science 266, 2011-2015.
36. KOFF A., OHTSUKI M., POLIAK K., ROBERTS J. M. & MASSAGUE J. (1993). Negative regulation of G1 in mammalian cells: inhibition of cyclin E. dependent kinase by TGFβ. Science 260, 536-539.
37. KRAMER M., STEIN B., MAI J., KUNZ E., KONIG H., LOFERER H. et al. (1990). Radiation induced activation of transcription in mammalian cells. Radiat. Environ. Biophys. 29, 303-313.
38. KUNDU N., ZHANG J. & FULTON A. M. (1995). Sublethal oxidative stress inhibits tumor cell adhesion and enhances experimental metastases of a murine mammary carcinoma. Clin. Exp. Metast. 13, 1, 16-22.
39. LANGRIDGE J. (1991). Molecular Genetics and Comparative Evolution Vol. 1. Taunton: Research Studies Press.
40. LEVINE A. S., MOMAND J. & FINLAY C. A. (1991). The p53 tumor suppressor gene. Nature 351, 453-455.
41. LINDQUIST S. & CRAIG E. A. (1988). The heat shock proteins. An. Rev. Genet. 22, 631-677.
42. LIOTTA L. A., MANDLER R., MURANO G., KATZ D. A., GORDON C. R. K., CHIANG P. K. & SCHIFFMAN E. (1986). Tumor cell autocrine motility factor. Proc. Natl. Acad. Sci. 83, 3302-3306.
43. LIOTTA L. A. & STETLER-STEVENSON W. F. (1991). Tumor invasion and metastases: an imbalance of positive and negative regulation. Cancer Res. (suppl.) 51, 5059-5064.
44. LOEB L. A. (1994). Microsatellite instability: marker of a mutator phenotype in cancer. Cancer Res. 54, 5054-5063.
45. LURIA S. E. & DELBRUCK M. (1943). Mutations of bacteria from virus sensitivity to virus resistance. Genetics 28, 491-495.
46. MALINS D. C., POLISSER N. L., NISHIDIKA K., HOLMES E. H., GARDNER H. S. & SUNSELMAN S. J. (1995). The etiology and prediction of breast cancer. Fourier transform-infrared spectroscopy reveals progressive alterations in DNA leading to a cancer like phenotype in a high proportion of normal women. Cancer 75, 2, 503-517.
47. MARGULIS L. (1970). Origin of eukaryote cell. Vol. 1 Yale: University Press.
48. MINTZ B. & ILLMENSEE K. (1975). Normal genetically mosaic mice produced from malignant teratocarcinoma cells. Proc. Natl. Acad. Sci. USA 72, 3585-3589.
49. MOMAND J., ZAMBETTI G. P., OLSON D. C., GEORGE D. & LEVINE A. S. (1992). The mdm2 oncogene product forms a complex with the p53 protein and inhibits p53 mediated transactivation. Cell 69, 1237-1245.
50. MURRAY A. & HUNT T. (1993). The cell cycle, an introduction. Oxford: University Press.
51. NOBORI T., MIURA K., WU D. J., LOIS A., TAKABAYASHI K. & CARSON D. A. (1994). Deletions of the cyclin-dependant kinase inhibitors gene in multiple human cancers. Nature 368, 753-756.
52. NORBURY C. & NURSE P. (1992). Animal cell cycles and their control. Annual Rev. Biochem. 61, 441-470.
53. NOWELL P. C. (1976). The clonal evolution of tumor cell populations. Science 194, 23-28.
54. NURSE P. (1990). Universal control mechanism regulating onset of M-phase. Nature 344, 503-508.
55. NYSTROM T. & NEIDHARDT F. C. (1992). Cloning mapping and nucleotide sequencing of a gene encoding a universal stress protein in Escherichia coli. Mol. Microbiol. 6, 3187-3198.
56. NYSTROM T. & NEIDHARDT F. C. (1994). Expression and role of the universal stress protein Usp A, of Escherichia coli during growth arrest. Mol. Microbiol. 11, 537-544.
57. OSTERREICH S., WENG C. N., KIU M., HIBENBEK J. G., OXBORNE C. K. & FUQUA S. W. (1993). The small heat shock protein hsp27 is correlated with growth and drug resistance in human breast cancer lines. Cancer Res. 4443-4448.
58. PALOMBO F., HUGHES M., JIRICNY J., TRUONG O. & HSUAN J. (1994). Mismatch repair and cancer. Nature 367, 417.
59. PARODI S. & BRAMBILLA G. (1977). Relationships between mutation and transformation frequencies in mammalian cells treated in vitro with chemical carcinogens. Mut. Res. 47, 53-74.
60. PARSHAD R. & SANDFORD K. (1968). Effect of horse serum, fetal calf serum, calf serum, boven serum and fetuin on neoplasic conversion and chromosomes of mouse embryocells in vitro. Natl. Cancer Inst. 41, 767-779.
61. PARSON R., LI G. M., LONGLEY M., MODRICH P., LIU B., BERK T., HAMILTON S. R., KINZLER K. W. & VOGELSTEIN B. (1995). Mismatch repair deficiency in phenotically normal cells. Science 268, 738-740.
62. PAULSSON M. (1992). Basement membrane proteins: structure assembly and cellular interaction. Crit. Rev. Biochem. Mol. Biol. 27, 93-127.
63. REED S. (1993). Bcl2 and the regulation of programmed cell death. J. Cell. Biol. 124, 1-6.
64. RUBIN H. (1980). Is somatic mutation the major mechanism of malignant transformation? J. Natl Cancer Inst. 61, 5, 995-1000.
65. SAMAK R., EDELSTEIN R. & ISRAEL L. (1982). Immunosuppressive effects of acute phase reactant proteins and its relevance to cancer. Cancer Immunol. Immunther. 13, 38-43.
66. SASTRE-GARAU X. (1994). Anatomical and pathological aspects of metastatic spread of tumor cells. Bull. Inst. Pasteur 92, 4, 290-293.
67. SCHIPPER H., GOH C. R. & WANG T. L. (1995). Shifting the cancer paradigm. Must we kill to cure? J. Clin. Oncol. 13, 4, 801-807.
68. SCHWARTZ R. M. & DAYHOFF M. O. (1978). Origin of prokaryotes, eukaryotes mitochondria and chloroplasts. Science 199, 395-403.
69. SEDGWICK S. G. & YARRANTON G. T. (1982). How cells in distress use SOS. Nature 296, 606-607.
70. SERVICE R. (1994). Slow DNA repair implicated in mutations found in tumors. Science 263, 1374.
71. SLINGERLAND J. M. et al. (1994). A novel inhibitor of cyclin cdk activity detected in transforming growth factor β arrested epithelial cells. Mol. Cell. Biol. 14, 3684-3694.
72. SPORN M. B. & ROBERTS A. B. (1983). Role of retinoids in differentiation and carcinogenesis. Cancer Res. 43, 3304-3440.
73. STEEG P. S., BEVILACQUA G., KOPPER L., THORGEIRSSON U. P., TALMADGE J. E., LIOTTA L. & SOBEL M. E. (1988). Evidence for a novel gene associated with low metastatic potential. J. Natl Cancer Inst. 80, 200-204.
74. TAKODA T., HAYASHI T., ARAKAWA M. & KOMINAMI R. (1992). Telomere elongation frequently observed during tumor metastasis. Jpn J. Cancer Res. 83, 112-127.
75. TROSKO J. E. (1987). Mechanisms of tumor promotion: possible role of inhibited intercellular communication. Eur. J. Cancer Clin. Onc. 23, 599-681.
76. USMANI B. A. (1993). Genomic instability and metastatic progression. Pathology 61, 109-116.
77. WEINBERG R. A. (1982). Oncogenes of spontaneous and chemically induced tumors. Adv. Cancer Res. 36, 149-164.
78. WEINBERG R. A. (1991). Tumor suppressor genes. Science 254, 1138-1146.
79. WEINBERG R. A. (1994). Molecular mechanisms of cancerogenesis. In: Introduction to Molecular Medicine (Leder P., Clayton D. A., Rubenstein E. eds) New York: Scientific American.
80. ZUCKER S. & BIWAS C. (1994). Tumor collagenase stimulating factor: a paracrine stimulator of fibroblast production of matrix metalloproteinases in cancer. Bull. Inst. Pasteur 92, 284-289.